These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 22466334)

  • 1. PROKR2 variants in multiple hypopituitarism with pituitary stalk interruption.
    Reynaud R; Jayakody SA; Monnier C; Saveanu A; Bouligand J; Guedj AM; Simonin G; Lecomte P; Barlier A; Rondard P; Martinez-Barbera JP; Guiochon-Mantel A; Brue T
    J Clin Endocrinol Metab; 2012 Jun; 97(6):E1068-73. PubMed ID: 22466334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variations in PROKR2, but not PROK2, are associated with hypopituitarism and septo-optic dysplasia.
    McCabe MJ; Gaston-Massuet C; Gregory LC; Alatzoglou KS; Tziaferi V; Sbai O; Rondard P; Masumoto KH; Nagano M; Shigeyoshi Y; Pfeifer M; Hulse T; Buchanan CR; Pitteloud N; Martinez-Barbera JP; Dattani MT
    J Clin Endocrinol Metab; 2013 Mar; 98(3):E547-57. PubMed ID: 23386640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digenic Inheritance of PROKR2 and WDR11 Mutations in Pituitary Stalk Interruption Syndrome.
    McCormack SE; Li D; Kim YJ; Lee JY; Kim SH; Rapaport R; Levine MA
    J Clin Endocrinol Metab; 2017 Jul; 102(7):2501-2507. PubMed ID: 28453858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss-of-function mutations in the genes encoding prokineticin-2 or prokineticin receptor-2 cause autosomal recessive Kallmann syndrome.
    Abreu AP; Trarbach EB; de Castro M; Frade Costa EM; Versiani B; Matias Baptista MT; Garmes HM; Mendonca BB; Latronico AC
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4113-8. PubMed ID: 18682503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-exome sequencing identifies homozygous GPR161 mutation in a family with pituitary stalk interruption syndrome.
    Karaca E; Buyukkaya R; Pehlivan D; Charng WL; Yaykasli KO; Bayram Y; Gambin T; Withers M; Atik MM; Arslanoglu I; Bolu S; Erdin S; Buyukkaya A; Yaykasli E; Jhangiani SN; Muzny DM; Gibbs RA; Lupski JR
    J Clin Endocrinol Metab; 2015 Jan; 100(1):E140-7. PubMed ID: 25322266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum.
    Cole LW; Sidis Y; Zhang C; Quinton R; Plummer L; Pignatelli D; Hughes VA; Dwyer AA; Raivio T; Hayes FJ; Seminara SB; Huot C; Alos N; Speiser P; Takeshita A; Van Vliet G; Pearce S; Crowley WF; Zhou QY; Pitteloud N
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3551-9. PubMed ID: 18559922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A heterozygous microdeletion of 20p12.2-3 encompassing PROKR2 and BMP2 in a patient with congenital hypopituitarism and growth hormone deficiency.
    Parsons SJH; Wright NB; Burkitt-Wright E; Skae MS; Murray PG
    Am J Med Genet A; 2017 Aug; 173(8):2261-2267. PubMed ID: 28586151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2.
    Dodé C; Teixeira L; Levilliers J; Fouveaut C; Bouchard P; Kottler ML; Lespinasse J; Lienhardt-Roussie A; Mathieu M; Moerman A; Morgan G; Murat A; Toublanc JE; Wolczynski S; Delpech M; Petit C; Young J; Hardelin JP
    PLoS Genet; 2006 Oct; 2(10):e175. PubMed ID: 17054399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel dysfunctional LHX4 mutation with high phenotypical variability in patients with hypopituitarism.
    Castinetti F; Saveanu A; Reynaud R; Quentien MH; Buffin A; Brauner R; Kaffel N; Albarel F; Guedj AM; El Kholy M; Amin M; Enjalbert A; Barlier A; Brue T
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2790-9. PubMed ID: 18445675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative phenotypic study of kallmann syndrome patients carrying monoallelic and biallelic mutations in the prokineticin 2 or prokineticin receptor 2 genes.
    Sarfati J; Guiochon-Mantel A; Rondard P; Arnulf I; Garcia-Piñero A; Wolczynski S; Brailly-Tabard S; Bidet M; Ramos-Arroyo M; Mathieu M; Lienhardt-Roussie A; Morgan G; Turki Z; Bremont C; Lespinasse J; Du Boullay H; Chabbert-Buffet N; Jacquemont S; Reach G; De Talence N; Tonella P; Conrad B; Despert F; Delobel B; Brue T; Bouvattier C; Cabrol S; Pugeat M; Murat A; Bouchard P; Hardelin JP; Dodé C; Young J
    J Clin Endocrinol Metab; 2010 Feb; 95(2):659-69. PubMed ID: 20022991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal, pituitary magnetic resonance, LHX4 and HESX1 evaluation in patients with hypopituitarism and ectopic posterior pituitary lobe.
    Melo ME; Marui S; Carvalho LR; Arnhold IJ; Leite CC; Mendonça BB; Knoepfelmacher M
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):95-102. PubMed ID: 17201807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PROKR2 and PROK2 mutations cause isolated congenital anosmia without gonadotropic deficiency.
    Moya-Plana A; Villanueva C; Laccourreye O; Bonfils P; de Roux N
    Eur J Endocrinol; 2013 Jan; 168(1):31-7. PubMed ID: 23082007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline prokineticin receptor 2 (PROKR2) variants associated with central hypogonadism cause differental modulation of distinct intracellular pathways.
    Libri DV; Kleinau G; Vezzoli V; Busnelli M; Guizzardi F; Sinisi AA; Pincelli AI; Mancini A; Russo G; Beck-Peccoz P; Loche S; Crivellaro C; Maghnie M; Krausz C; Persani L; Bonomi M;
    J Clin Endocrinol Metab; 2014 Mar; 99(3):E458-63. PubMed ID: 24276467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between Pituitary Stalk Interruption Syndrome and Prokineticin Receptor 2 and Prokineticin 2 Mutations.
    Han BY; Li LL; Wang CZ; Guo QH; Lv ZH; Mu YM; Dou JT
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Feb; 38(1):37-41. PubMed ID: 26956854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kallmann syndrome caused by mutations in the PROK2 and PROKR2 genes: pathophysiology and genotype-phenotype correlations.
    Sarfati J; Dodé C; Young J
    Front Horm Res; 2010; 39():121-132. PubMed ID: 20389090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical lessons learned in constitutional hypopituitarism from two decades of experience in a large international cohort.
    Jullien N; Saveanu A; Vergier J; Marquant E; Quentien MH; Castinetti F; Galon-Faure N; Brauner R; Marrakchi Turki Z; Tauber M; El Kholy M; Linglart A; Rodien P; Fedala NS; Bergada I; Cortet-Rudelli C; Polak M; Nicolino M; Stuckens C; Barlier A; Brue T; Reynaud R;
    Clin Endocrinol (Oxf); 2021 Feb; 94(2):277-289. PubMed ID: 33098107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary stalk interruption syndrome in 83 patients: novel HESX1 mutation and severe hormonal prognosis in malformative forms.
    Reynaud R; Albarel F; Saveanu A; Kaffel N; Castinetti F; Lecomte P; Brauner R; Simonin G; Gaudart J; Carmona E; Enjalbert A; Barlier A; Brue T
    Eur J Endocrinol; 2011 Apr; 164(4):457-65. PubMed ID: 21270112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the prokineticin 2 pathway in human reproduction: evidence from the study of human and murine gene mutations.
    Martin C; Balasubramanian R; Dwyer AA; Au MG; Sidis Y; Kaiser UB; Seminara SB; Pitteloud N; Zhou QY; Crowley WF
    Endocr Rev; 2011 Apr; 32(2):225-46. PubMed ID: 21037178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classical and non-classical causes of GH deficiency in the paediatric age.
    Di Iorgi N; Morana G; Allegri AE; Napoli F; Gastaldi R; Calcagno A; Patti G; Loche S; Maghnie M
    Best Pract Res Clin Endocrinol Metab; 2016 Dec; 30(6):705-736. PubMed ID: 27974186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic analysis in patients with Kallmann syndrome: coexistence of mutations in prokineticin receptor 2 and KAL1.
    Canto P; Munguía P; Söderlund D; Castro JJ; Méndez JP
    J Androl; 2009; 30(1):41-5. PubMed ID: 18723471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.